Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc. (BOLT) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bolt · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Bolt Biotherapeutics, Inc. (BOLT) measures how much investors pay for each dollar of the company's trailing earnings. BOLT's current PE ratio of N/A is calculated by dividing its stock price of $4.72 by its TTM earnings per share of -$15.82.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2018 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Bolt Biotherapeutics, Inc.You BOLT | $9M | N/A | — | -$15.82 |
 AEON Biopharma, Inc. AEON | $9M | N/A | — | -$3.95 |
 Cingulate Inc. CING | $25M | N/A | — | -$4.13 |
 Cellectar Biosciences, Inc. CLRB | $8M | N/A | — | -$8.35 |
 Evogene Ltd. EVGN | $5M | N/A | — | -$1.08 |
 Imunon, Inc. IMNN | $5M | N/A | — | -$6.83 |
 IN8bio, Inc. INAB | $7M | N/A | — | -$4.44 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-17.85 | — | |
2024-12-31 FY2024 | — | $-1.65 | — | |
2023-12-31 FY2023 | — | $-1.83 | — | |
2022-12-31 FY2022 | — | $-2.36 | — | |
2021-12-31 FY2021 | — | $-2.64 | — | |
2020-12-31 FY2020 | — | $-1.68 | — | |
2019-12-31 FY2019 | — | $-3.81 | — | |
2018-12-31 FY2018 | — | $-5.96 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Bolt Biotherapeutics, Inc. (BOLT) measures how much investors pay for each dollar of the company's trailing earnings. BOLT's current PE ratio of N/A is calculated by dividing its stock price of $4.72 by its TTM earnings per share of -$15.82.
Frequently asked questions
BOLT pe ratio · 6 questionsBOLT's current PE ratio is N/A as of 2026-06-09, based on a stock price of $4.72 and TTM EPS of -$15.82. Data sourced from Financial Modeling Prep via BOLT's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Bolt Biotherapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09